4//SEC Filing
AVEO PHARMACEUTICALS INC 4
Accession 0001209191-15-003161
CIK 0001325879operating
Filed
Jan 7, 7:00 PM ET
Accepted
Jan 8, 4:36 PM ET
Size
7.3 KB
Accession
0001209191-15-003161
Insider Transaction Report
Form 4
Gyuris Jeno
SVP, Head of Research
Transactions
- Disposition to Issuer
Common Stock
2015-01-06−13,200→ 80,615 total - Sale
Common Stock
2015-01-07$0.80/sh−4,484$3,589→ 76,131 total
Footnotes (3)
- [F1]Shares underlying such disposition to the issuer were forfeited by the reporting person pursuant to the terms of an award of restricted stock granted to the reporting person on June 26, 2013 in connection with the determination of the issuer's Compensation Committee that certain specified strategic performance objectives were not met.
- [F2]The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 12, 2013, which was implemented to cover taxable events related to the partial vesting of certain restricted stock.
- [F3]The price reported in this Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $0.78 to $0.82, inclusive. The reporting person undertakes to provide AVEO Pharmaceuticals, Inc., any security holder of AVEO Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the ranges set forth in this footnote.
Documents
Issuer
AVEO PHARMACEUTICALS INC
CIK 0001325879
Entity typeoperating
Related Parties
1- filerCIK 0001325879
Filing Metadata
- Form type
- 4
- Filed
- Jan 7, 7:00 PM ET
- Accepted
- Jan 8, 4:36 PM ET
- Size
- 7.3 KB